Abstract
Purpose:
Pre-eclampsia (PE) is a serious complication of pregnancy characterized by high blood pressure, proteinuria, compromised fetal blood supply, and potential organ damage. The superficial location of the eye makes it an ideal target for characterization hemodynamics. Our aim was to discern the impact of PE on ocular blood flow.
Methods:
18 MHz plane-wave ophthalmic ultrasound scanning was performed on subjects with PE (n = 26), chronic or gestational hypertension (n = 8), and normal controls (n = 19) within 72 hours of delivery. Duplicate three-second long scans of the posterior pole including the optic nerve were acquired at 6000 images/sec for evaluation of the central retinal artery and vein and the short posterior ciliary arteries. The choroid was scanned at 1000 images/sec. Doppler analysis provided values of pulsatile flow velocity and resistance indexes.
Results:
End diastolic velocity was higher, and pulsatility and resistive indexes were significantly lower in the choroid, central retinal artery and short posterior ciliary arteries in PE than in controls. Blood pressure was elevated in PE with respect to controls and was negatively correlated with resistance.
Conclusions:
Although vasoconstriction is considered characteristic of PE, we found reduced resistance in the orbital vessels and choroidal arterioles, implying vasodilation at this level. Future studies incorporating optical coherence tomography angiography for characterization of the retina and choriocapillaris in conjunction with plane-wave ultrasound scanning, particularly in late pregnancy, might address this conundrum.
Translational Relevance:
Use of plane-wave ultrasound scanning for evaluation ocular blood flow in women at risk for PE may offer an avenue towards early detection and clinical intervention.
Pre-eclampsia (PE) is a rapidly progressive multisystem disorder characterized by the acute onset of hypertension occurring usually after 20 weeks of gestation and frequently associated with proteinuria and edema. Severe manifestations include reduced organ perfusion secondary to vasospasm and activation of the coagulation cascade.
1 It affects 4% to 7% of pregnant women and is one of the most serious complications of pregnancy. Despite extensive research, the cause of PE remains elusive.
2
PE is fundamentally a disease of the vasculature and is directly implicated in an array of major maternal morbidities and adverse perinatal outcomes. Women destined to develop PE have increased vascular reactivity well before they become symptomatic. Identification of high-risk patients is based on clinical history, especially prior PE, diabetes, renal disease, and chronic hypertension.
3
Presymptomatic warning of an elevated risk for development of PE would be a valuable clinical tool. A marker for severe progression could be crucial to the life and health of both mother and child. Severe complications of PE account for approximately 63,000 maternal deaths annually worldwide, with mortality rates especially high in less developed countries.
4 In the United States, PE accounts for approximately 16% of all maternal deaths and risk of fetal death is highly elevated, especially for PE occurring in the preterm period.
5,6 Women suffering PE are also at risk for high blood pressure, stroke, heart and renal disease, and vascular dementia later in life.
7
While the placenta might be regarded as the most intuitive target for vascular imaging for assessment of PE risk,
8 it is far less accessible to high-resolution imaging of the vasculature than is the eye, where the retinal microvasculature can be visualized optically. This is especially true given recent advances in ocular imaging, such as optical coherence tomography angiography (OCT-A). Whereas the placenta is poorly placed for routine, high-resolution imaging, the eye is superficial, has a rich retinal and choroidal vasculature, and can be imaged noninvasively in near-microscopic detail.
In ophthalmology, B-scan instruments generally consist of mechanically scanned single-element transducers. These emit a focused ultrasound beam, and images are produced by measurement of the probe orientation and range and amplitude of echoes. Ophthalmic B-scan instruments typically produce about 10 images/sec and provide no information on blood-flow.
Linear array probes are dominant in other clinical specialties. With electronic rather than mechanical scanning, scan rate is 10 times faster, and Doppler techniques can be used to produce color-flow images superimposing regions of flow over the gray-scale structural image. This technology, however, has made negligible impact in ophthalmology because such systems generally exceed Food and Drug Administration (FDA) guidelines
9 for ophthalmic intensity thresholds.
Plane-wave ultrasound scanning is a recent technologic advance that offers the advantages of linear arrays with compliance to FDA-guidelines.
10,11 In this imaging mode, all array elements emit at once to produce an unfocused wavefront. Echo data received by the many elements are then brought into focus by postprocessing using a “delay-and-sum” algorithm, which is the inverse of how element firings would be timed to produce a converging, focused beam. Because the plane-wave is unfocused on transmit, ultrasound intensity is substantially lower than when using a standard scanned, focused beam, and because there is no scanning (electronic or mechanical), the imaging rate can be ∼1000 times faster than with a mechanically scanned probe. Given the two-way pulse/echo transit time of the eye, roughly 15,000 B-scan images can be acquired per second.
We developed plane-wave ultrasound scanning for imaging of the eye and reported imaging and measurement of blood-flow in the major vessels and choroid.
8,12
In this study, we describe plane-wave ultrasound imaging and measurement of ocular blood-flow in 53 subjects scanned post-partum within 72 hours of delivery, 26 of whom had PE.
Patients were transported to the Harkness Eye Institute for ultrasound examination. Ophthalmic plane-wave ultrasound scanning was performed within 72 hours of delivery by a single investigator (RHS). Scanning was performed through closed eyelids with the subject in a seated position. GenTeal (Alcon, Geneva, Switzerland) ocular lubricant was applied to the probe surface as an acoustic coupling agent. Scanning was performed with minimum pressure to the eyelid to enable visualization and measurement of flow. For assessment of the retrobulbar vessels, the scan was in a horizontal plane encompassing the optic nerve. For the choroid, scans were in a horizontal plane just superior to the optic nerve. The dimension of the scanned region was approximately 12.8 mm laterally by 8 mm axially. Duplicate scans were acquired on both eyes. The scanning procedure had a duration of approximately five to ten minutes per eye.
We developed MATLAB (The MathWorks, Inc., Natick, MA, USA) programs to control transmit and receive of all transducer elements, enabling transmission of plane waves at multiple angles. Echo data received by the linear-array transducer elements were quadrature sampled at 62.5 MHz at 14-bits per sample.
In real-time “flash Doppler” mode,
15 color-flow power Doppler was superimposed on grayscale plane-wave B-mode images. Although Doppler resolution and sensitivity are relatively modest in this mode, it allows identification of relevant ocular structures and flow, enabling orientation of the probe for data acquisition.
Once the probe was properly oriented, we acquired high-resolution data from the posterior pole for approximately three seconds at 6 kHz, compounding echo data from two angled transmissions at ±9°. At this acquisition rate, velocities of up to 140 mm/sec could be measured before reaching the alias limit. For choroidal “slow flow,” 10 angles were compounded and acquired at 1 kHz.
Statistical analysis was performed with IBM SPSS, Version 25 (IBM Corp., Armonk, NY). Means and standard deviations of systemic BP parameters and ultrasound-determined flow parameters were determined for each group and analysis of variance (ANOVA) performed. Correlation coefficients between BP and flow parameters were determined. Correlation coefficients for all measurements between left and right eyes were determined. Focusing specifically on sPE, we compared Doppler parameters in control versus sPE eyes by vessel using a general linear model (GLM) repeated measures procedure in which values from fellow eyes were treated as repeated measures to control for potential correlation between fellow eyes. Last, we repeated the GLM analysis with MAP as a covariate.
Table 2 summarizes mean systemic parameters by diagnostic group. PE and HTN groups had higher BP than controls, but the diastolic/systolic ratio and heart rate were not significantly different.
Table 2. Systemic Blood Pressure Parameters (in mm Hg) and ANOVA by Group
Table 2. Systemic Blood Pressure Parameters (in mm Hg) and ANOVA by Group
Significant correlations between systemic BP and Doppler parameters (considering all groups together) are listed in
Table 3. The table demonstrates significant correlations between systolic and diastolic BP and MAP with ocular flow parameters, particularly resistance (PE and RI). This was particularly notable in the sPE group, where diastolic BP had correlation coefficients of −0.562 and −0.529 with PI in the CRA and SPCA, respectively. This negative correlation was also evident to a lesser degree in control subjects.
Table 3. Statistically Significant Correlations of Ocular Flow Velocity Parameters with Systemic Blood-Pressure Variables in the CRA, CRV, and SPCA
Table 3. Statistically Significant Correlations of Ocular Flow Velocity Parameters with Systemic Blood-Pressure Variables in the CRA, CRV, and SPCA
We also examined Doppler parameters for correlation with the time interval between delivery and the ultrasound examination. ANOVA showed no significant difference in the time interval between groups. We found positive correlations between the interval and diastolic (R = 0.346, P = 0.020) and mean velocity (R = 0.324, P = 0.030), but only in the short posterior ciliary artery. We repeated the analysis for just the sPE group and found no significant correlation between Doppler parameters and time interval.
Table 4. Choroidal Flow Velocity Parameters With ANOVA by Group
Table 4. Choroidal Flow Velocity Parameters With ANOVA by Group
Mean Doppler parameters by group and their standard deviations are presented for each vessel in
Tables 4 to
7. ANOVA shows significant differences among groups. EDV, V
MEAN, RI, and PI were all significant in the choroid. PI was significant in all vessels with exception of the CRV (which has negligible pulsatility).
Table 5. Central Retinal Artery Flow Velocity Parameters With ANOVA by Group
Table 5. Central Retinal Artery Flow Velocity Parameters With ANOVA by Group
Although there was a trend toward increased flow velocities in the HTN group compared with controls, this was not statistically significant. The low number of cases in this group, however, makes this a tentative finding.
Table 8 provides correlation coefficients between left and right eyes of each measurement. In most cases, correlation was small to moderate (
R < 0.5), but all measurements were highly correlated (
R > 0.6) in the SPCA. This is a surprising finding given the irregular directionality of the SPCAs but perhaps reflects greater averaging, because often more than one SPCA was imaged per scan.
GLM findings comparing Doppler parameters in control versus sPE eyes are presented in
Table 9. Significant differences in EDV were found in the choroid and CRA, for V
MEAN in the CRA, and for RI and PI in all vessels other than the CRV.
Table 10 repeats this analysis, but adding MAP as a covariate. When taking MAP into account, no variable attained statistical significance.
The authors thank Inez Nelson for her assistance in organizing data.
Supported by NIH Grants R01 EY025215, P30 EY019007 and National Center for Advancing Translational Sciences grant UL1TR001873, the New York Community Trust—Theresa Dow Wallace Fund and an unrestricted grant to Columbia Dept. of Ophthalmology from Research to Prevent Blindness. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Disclosure: R.H. Silverman, None; R. Urs, None; R.J. Wapner, None; S. Bearelly, None